Paul is the Founder & CEO of Impatient Health. He is often described as the ‘pharma provocateur’ for rethinking and realizing the huge unfulfilled potential of the life sciences industry. His journey started in 2003 with ‘eyeforpharma’ where he quickly created the pharmaceutical industry’s largest and most influential events. The company was acquired by Reuters in 2019. In 2020 he set up Impatient Health, an industry think-tank and consultancy. Paul counts the industry’s CEOs and innovators amongst his friends, and is a regular speaker, host, author and commentator.
Chandana is a medical doctor with work, research and educational experience across European, American and Asian markets. After a stint in clinical practice in tertiary and primary care, she has engaged in leadership positions in the digital health space to bring to life market innovations that bridge gaps in healthcare. She likes to bring ideas to life by supporting young digital health businesses to become stronger players. She is currently driving global collaborations in digital health and medicine as HealthXLs CEO. HealthXL is leading the charge in connecting leaders from across the globe to solve healthcare challenges.
She enjoys being surrounded by passionate, committed & ”figure-it-out” people who push the envelope. She believes great work happens when you enjoy the journey.
Michelangelo Canzoneri, PhD, serves as the Global Head of Group Smart Manufacturing at Merck KGaA, based in Darmstadt, Germany. A seasoned leader in digital transformation, he acts as the key business interface across the Life Science, Healthcare, and Electronics sectors. His role is instrumental in steering Smart Manufacturing and Supply Chain Analytics, fostering cross-sector collaboration, and advancing innovative solutions.
In addition to his corporate responsibilities, Michelangelo is a professor at the University of Applied Sciences and Goethe Business School in Frankfurt.
He cultivates a culture of intellectual curiosity and continuous learning, preparing the next generation of industry leaders.
An advocate for technological advancement, Michelangelo promotes the integration of process analytical technologies, data analytics, and artificial intelligence as essential components for the industry’s future.
Former Vice President and Head of Global Digital Strategy, BMS, USA
Leslie Anne Fendt
Dr. Leslie Anne Fendt works at Roche leading the development and commercialization of one of Roche’s first Software-As-Medical-Device (SaMD) products, while simultaneously contributing to building out Roche’s overall digital health infrastructure, operating model, and strategy.
Previously at Roche she was leading the global commercialization of a novel immunology treatment expected to generate >2 billion annual sales by helming a multidisciplinary team of 50 to define its go-to-market strategy and operationalize the product launch across 100+ affiliates. Before that, Leslie held a series of roles in sales, marketing, strategy, insights, and launch excellence both at global and affiliate level.
Leslie holds a master in Organic Chemistry with minors in business and computer science from Uni Basel, CH, and Cambridge, UK, and a PhD in Nanosciences from ETH Zurich. She is a board member of the Swiss Chemical Society and an active voice in the Digital Health/Tech community. Leslie lives with her partner, three daughters, and two cats in Switzerland.
Isabelle Widmer is the founder and CEO of Elytra, a life science consulting firm based in Switzerland.
A consultant and executive coach, Isabelle has over a decade of experience supporting clients to create successful growth strategies and to identify and implement operational improvements across channels, geographies, and markets. She has worked with firms ranging from the top pharmaceutical companies to biotech startups.
Isabelle is a published author and regular conference speaker. She has broad experience in market access considerations, medical affairs excellence, medical information, customer engagement, digitalization, data husbandry and data analytics and in supporting global transformation programmes.
Prior to consulting Isabelle worked in the pharmaceutical industry, as a clinician and in basic research at the National Institutes of Health. Outside of work, Isabelle loves the outdoors and is an avid cyclist. She earned her MD and DAS in pharmaceutical medicine from the University of Basel.